I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:
Iveson, Timothy J
;
Kerr, Rachel S
;
Saunders, Mark P
...
The Lancet Oncology, 1470-2045, 2018, 19:4, s. 562-578. , 2018
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353105
RT Journal T1
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT) : an international, randomised, phase 3, non-inferiority trial
UL https://suche.suub.uni-bremen.de/peid=base-ftuppsalauniv:oai:DiVA.org:uu-353105&Exemplar=1&LAN=DE A1 Iveson, Timothy J A1 Kerr, Rachel S A1 Saunders, Mark P A1 Cassidy, Jim A1 Henrik Hollander, Niels A1 Tabernero, Josep A1 Haydon, Andrew A1 Glimelius, Bengt A1 Harkin, Andrea A1 Allan, Karen A1 McQueen, John A1 Scudder, Claire A1 Boyd, Kathleen Anne A1 Briggs, Andrew A1 Waterston, Ashita A1 Medley, Louise A1 Wilson, Charles A1 Ellis, Richard A1 Essapen, Sharadah A1 Dhadda, Amandeep S A1 Harrison, Mark A1 Falk, Stephen A1 Raouf, Sherif A1 Rees, Charlotte A1 Olesen, Rene K A1 Propper, David A1 Bridgewater, John A1 Azzabi, Ashraf A1 Farrugia, David A1 Webb, Andrew A1 Cunningham, David A1 Hickish, Tamas A1 Weaver, Andrew A1 Gollins, Simon A1 Wasan, Harpreet S A1 Paul, James PB Uppsala universitet, Experimentell och klinisk onkologi; Southampton Univ Hosp NHS Fdn Trust, Southampton SO16 0YD, Hants, England; Univ Oxford, Dept Oncol, Oxford, England; Christie Hosp, Manchester, Lancs, England; Univ Glasgow, Inst Canc Sci, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; Zealand Univ Hosp, Dept Oncol & Palliat Care, Naestved, Denmark; Vall dHebron Univ Hosp, Barcelona, Spain;Univ Autonoma Barcelona, CIBERONC, Inst Oncol, Barcelona, Spain; Australasian Gastrointestinal Trials Grp, Melbourne, Vic, Australia; Univ Oxford, Dept Oncol, OCTO, Oxford, England; Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland;Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Ctr Hlth & Policy Outcomes, New York, NY 10021 USA; Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; Royal United Hosp, Bath, Avon, England; Addenbrookes Hosp, Cambridge, England; Roy... YR 2018 K1 Cancer and Oncology K1 Cancer och onkologi JF The Lancet Oncology, 1470-2045, 2018, 19:4, s. 562-578 LK http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353105 DO http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-353105 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)